Pharma stocks underperform in 2026 due to pricing reforms

Major pharmaceutical companies like Pfizer, Merck, and Eli Lilly would face margin pressure from drug price controls. Analysts expect these stocks to decline by at least 10% relative to the S&P 500 in 2026.

Implied probability (Yes)

68%